| Cash Flow | 2025-09-30 | 2025-06-30 |
|---|---|---|
| Net cash used in financing activities | -24,134 | -7,680 |
| Net change in cash and cash equivalents | 6,472 | 12,031 |
| Cash and cash equivalents at beginning of period | 19,157 | - |
| Cash and cash equivalents at end of period | 25,629 | - |
Core Laboratories Inc. DE (CLB)
Core Laboratories Inc. DE (CLB)